Overall, the findings above implied that mRNA expressions of PRDX3/4/6 were remarkably correlated with BrCa patients’ both OS and RFS, which might be identified as promising biomarkers to predict the survival of BrCa patients. This evidence concerns the gene PRDX3 and invasive breast carcinoma.